Benign Fleck Retina

Benign fleck retina is a very rare, inherited eye condition that affects the retina, the light-sensitive tissue at the back of the eye. In this condition, an eye doctor looking into the eye will see a striking pattern of tiny, yellow-white spots or "flecks" scattered across the retina. These flecks are caused by a buildup of certain materials in the cells that support the retina, due to a specific genetic change inherited from both parents. The most important thing for patients to know about benign fleck retina is right in its name: it is "benign." Unlike many other genetic eye diseases that cause similar spots, this condition does not damage your vision. People with benign fleck retina have normal central vision, normal side vision, normal color vision, and no problems seeing in the dark. The spots spare the very center of the retina (the macula), which is responsible for sharp, detailed vision. Because it does not cause any symptoms, benign fleck retina is usually discovered completely by accident during a routine eye exam. If you have been diagnosed with this condition, you do not need any treatment, and you do not need to worry about going blind from it. Your eye doctor may want to monitor you occasionally, but your vision is expected to remain normal throughout your life.

Condition category: Stationary Disorder

Prevalence: Less than 1 in 1,000,000

Inheritance patterns: Autosomal Recessive

Age of onset: Birth to early childhood

Clinical overview: Benign familial fleck retina (BFFR) is a rare, autosomal recessive congenital abnormality belonging to the heterogeneous group of flecked retina syndromes. It is characterized by a striking and distinctive fundus appearance consisting of diffuse, polymorphous, yellow-white fleck-like lesions located at the level of the retinal pigment epithelium (RPE). These lesions typically extend to the far periphery of the retina but characteristically spare the foveal and macular regions. Clinically, the most defining feature of benign fleck retina is the complete absence of visual symptoms. Patients have normal visual acuity, normal color vision, normal dark adaptation, and no complaints of nyctalopia (night blindness). Furthermore, comprehensive electrophysiological assessments, including full-field electroretinogram (ERG), pattern ERG, and electrooculogram (EOG), are entirely normal. This normal functional profile is the key distinguishing factor between benign fleck retina and other, often progressive, flecked retina syndromes such as fundus albipunctatus or retinitis punctata albescens. The condition is caused by biallelic mutations in the PLA2G5 gene, which encodes group V phospholipase A2. The diagnosis is primarily clinical, supported by multimodal imaging. Fundus autofluorescence shows hyperautofluorescent spots corresponding to the flecks, indicating lipofuscin accumulation, while optical coherence tomography (OCT) reveals discrete deposits posterior to the photoreceptor inner/outer segment junction without disrupting the photoreceptor layer itself. Recognition of this specific entity is crucial for clinicians to avoid misdiagnosing it as a progressive retinal dystrophy and to provide accurate, reassuring prognostic information to the patient.

Patient and family guide: Benign fleck retina is a very rare, inherited eye condition that affects the retina, the light-sensitive tissue at the back of the eye. In this condition, an eye doctor looking into the eye will see a striking pattern of tiny, yellow-white spots or "flecks" scattered across the retina. These flecks are caused by a buildup of certain materials in the cells that support the retina, due to a specific genetic change inherited from both parents. The most important thing for patients to know about benign fleck retina is right in its name: it is "benign." Unlike many other genetic eye diseases that cause similar spots, this condition does not damage your vision. People with benign fleck retina have normal central vision, normal side vision, normal color vision, and no problems seeing in the dark. The spots spare the very center of the retina (the macula), which is responsible for sharp, detailed vision. Because it does not cause any symptoms, benign fleck retina is usually discovered completely by accident during a routine eye exam. If you have been diagnosed with this condition, you do not need any treatment, and you do not need to worry about going blind from it. Your eye doctor may want to monitor you occasionally, but your vision is expected to remain normal throughout your life.

Symptoms and clinical features: Benign fleck retina is entirely asymptomatic. Patients do not experience any visual disturbances. There is no loss of central visual acuity, no visual field constriction, no color vision abnormalities, and notably, no nyctalopia (night blindness). The condition is typically discovered incidentally during a routine fundus examination for unrelated reasons (such as refractive error screening).

Molecular pathology: Benign fleck retina is caused by biallelic mutations in the PLA2G5 gene, located on chromosome 1p36.13. This gene encodes group V phospholipase A2 (PLA2G5), a secreted calcium-dependent enzyme that catalyzes the hydrolysis of the sn-2 ester bond of glycerophospholipids to release free fatty acids and lysophospholipids. In the retina, PLA2G5 is believed to play a role in the phagocytosis of photoreceptor outer segments by the retinal pigment epithelium (RPE) and in the processing of lipid-rich outer segment membranes. The exact disease mechanism is not fully elucidated, but it is hypothesized that loss-of-function mutations in PLA2G5 disrupt normal lipid metabolism and clearance within the RPE. This metabolic defect leads to the abnormal accumulation of lipid-rich deposits, specifically lipofuscin-like material, within or beneath the RPE cells. These deposits manifest clinically as the characteristic yellow-white flecks seen on fundus examination. Despite this accumulation, the structural integrity of the photoreceptors and the overall function of the retina remain remarkably preserved, explaining the benign clinical nature of the condition.

Genetics: Benign fleck retina is inherited in an autosomal recessive pattern. This means that an affected individual must inherit two mutated copies of the PLA2G5 gene, one from each parent. The parents of an affected individual are typically obligate carriers (heterozygotes) and do not show any clinical signs or symptoms of the condition. When both parents are carriers, there is a 25% chance with each pregnancy of having an affected child, a 50% chance of having a child who is an asymptomatic carrier, and a 25% chance of having an unaffected, non-carrier child. Consanguinity (parents being closely related) increases the risk of autosomal recessive conditions and has been noted in several reported families with benign fleck retina. Genetic counseling is recommended for affected individuals and their families to discuss the inheritance pattern, risks to future offspring, and the benign nature of the condition to alleviate unnecessary anxiety regarding visual prognosis.

Diagnostic evaluation: Diagnosis of benign fleck retina is primarily clinical, based on the distinctive fundus appearance of diffuse, yellow-white, fleck-like lesions extending to the far periphery but sparing the macula. Multimodal imaging is highly supportive: fundus autofluorescence (FAF) reveals hyperautofluorescent lesions corresponding to the flecks due to lipofuscin accumulation, and enhanced depth optical coherence tomography (EDI-OCT) shows discrete deposit accumulation posterior to the photoreceptors' inner segment/outer segment junction without disrupting it. Crucially, electrophysiological testing, including full-field electroretinogram (ERG), pattern ERG, and electrooculogram (EOG), is completely normal, which distinguishes it from other flecked retina syndromes. Genetic testing confirming biallelic mutations in the PLA2G5 gene provides a definitive molecular diagnosis.

Differential diagnosis: Fundus albipunctatus, Retinitis punctata albescens, Stargardt disease, Fundus flavimaculatus, Familial drusen, Fleck retina of Kandori, Alport syndrome, Pseudoxanthoma elasticum

Natural history: The natural history of benign fleck retina is characterized by a stable, non-progressive course regarding visual function. The retinal flecks are congenital or appear early in life and may increase in number, size, and confluence over time, spreading further into the periphery. However, despite the increasing density of these lesions, the macula remains spared, and patients do not develop visual acuity loss, night blindness, or visual field defects. The condition remains asymptomatic throughout the patient's life.

Management and treatment research: Currently, there are no treatments available for benign fleck retina, nor are any required. Because the condition is entirely asymptomatic and does not cause any structural damage to the photoreceptors or progressive loss of visual function, medical or surgical intervention is unnecessary. Management consists solely of establishing the correct diagnosis to differentiate it from other, progressive flecked retina syndromes (such as Stargardt disease or retinitis punctata albescens). Once the diagnosis is confirmed, management involves reassuring the patient and their family about the excellent visual prognosis. Routine, periodic ophthalmic examinations may be recommended to monitor the stability of the condition and for general eye health, but no specific therapeutic monitoring is needed. There are no gene therapy trials or pipeline treatments for this condition, as the lack of pathology makes it an unsuitable and unnecessary target for such interventions.

Outlook: The prognosis for benign fleck retina is excellent. Patients maintain normal visual acuity, visual fields, and dark adaptation throughout their lives. The condition does not lead to blindness or visual impairment, and it has no negative impact on the patient's quality of life. No visual rehabilitation or low vision aids are required.

Epidemiology: Benign fleck retina is an extremely rare inherited retinal condition. Since its initial description in 1980 in a consanguineous family where seven siblings were affected, only a small number of families and sporadic cases have been reported in the medical literature worldwide. It has been identified in individuals of diverse ethnic backgrounds, including South Asian, Middle Eastern, and Caucasian descent. The condition affects both males and females equally. Due to its asymptomatic nature, it is likely underdiagnosed, typically only discovered incidentally during routine comprehensive eye examinations.

Selected references: 1. Sabel Aish SF, Dajani B. Benign familial fleck retina. Br J Ophthalmol. 1980. 2. Sergouniotis PI, et al. Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retina. Am J Hum Genet. 2011. 3. Mohan S, et al. Benign fleck retina. Oman J Ophthalmol. 2022. 4. Isaacs TW, et al. Benign fleck retina. Br J Ophthalmol. 1996.